A focus on quality and maintaining a strict 35.5-month schedule pushed the joint venture contractor on the Gaylord Pacific ...

Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...

Charles River initially unveiled a plan to adopt new alternative methods (NAMs), like computer models and human organoids, in ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

Novartis (NVS, Financials) is investing $23 billion over the next five years to expand its manufacturing and research ...

Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than 10 facilities, including seven new sites, and ...